Design, synthesis and biological evaluation of novel osimertinib derivatives as reversible EGFR kinase inhibitors.
Ding S, Gao Z, Hu Z, Qi R, Zheng X, Dong X, Zhang M, Shen J, Long T, Zhu Y, Tian L, Song W, Liu R, Li Y, Sun J, Duan W, Liu J, Chen Y.
Ding S, et al. Among authors: long t.
Eur J Med Chem. 2022 Aug 5;238:114492. doi: 10.1016/j.ejmech.2022.114492. Epub 2022 Jun 7.
Eur J Med Chem. 2022.
PMID: 35696862